Showing results (1551-1560 of 1,627) with videos related to
Sort By:
Pageof 163
Neurocritical Care|January 17, 2025
Psychosocial Support Needs and Preferences Among Family Caregivers of ICU Patients with Severe Acute Brain Injury: A Qualitative Thematic AnalysisDavid Y Hwang, Mira Reichman, Sarah M Bannon, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2020
Comprehensive Genomic Analysis of Translocation Renal Cell Carcinoma Reveals Copy-Number Variations as Drivers of Disease ProgressionJulian Marcon, Renzo G DiNatale, Alejandro Sanchez, et al.Molecular Cancer Research : MCR|May 27, 2021
High Response Rate and Durability Driven by HLA Genetic Diversity in Patients with Kidney Cancer Treated with Lenvatinib and PembrolizumabChung-Han Lee, Renzo G DiNatale, Diego Chowell, et al.Diabetes, Obesity & Metabolism|April 21, 2022
Therapeutic indications and metabolic effects of metreleptin in patients with lipodystrophy syndromes: Real-life experience from a national reference networkHéléna Mosbah, Marie-Christine Vantyghem, Estelle Nobécourt, et al.Journal of Medicinal Chemistry|February 22, 2024
Discovery of Potent and Selective Quinoxaline-Based Protease-Activated Receptor 4 (PAR4) Antagonists for the Prevention of Arterial ThrombosisXiaojun Zhang, Wen Jiang, Jeremy M Richter, et al.Journal of Neurology, Neurosurgery, and Psychiatry|August 21, 2019
Predicting symptomatic intracranial haemorrhage after mechanical thrombectomy: the TAG scoreMayra Montalvo, Eva Mistry, Andrew Davey Chang, et al.Journal of Medicinal Chemistry|March 16, 2022
Leveraging Structure-Based Drug Design to Identify Next-Generation MAT2A Inhibitors, Including Brain-Penetrant and Peripherally Efficacious LeadsMingzong Li, Zenon Konteatis, Nelamangala Nagaraja, et al.American Journal of Human Genetics|September 4, 2018
Fetal-Not Maternal-APOL1 Genotype Associated with Risk for Preeclampsia in Those with African AncestryKimberly J Reidy, Rebecca C Hjorten, Claire L Simpson, et al.European Journal of Endocrinology|April 23, 2017
Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomasHélène Lasolle, Christine Cortet, Fréderic Castinetti, et al.Science (New York, N.Y.)|November 9, 2019
Double <i>PIK3CA</i> mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitorsNeil Vasan, Pedram Razavi, Jared L Johnson, et al.Pageof 163